COMMUNIQUÉS West-GlobeNewswire

It’s Time to Build an “Own the Podium” Program for Home Care in Canada, Says VHA Home HealthCare CEO Carol Annett
06/02/2018
TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare: Expectations are high for Canada’s medal performance at this month’s Winter Olympics in PyeongChang. After our impressive showing in Rio, which surpassed [...]
Lumere Names John Cherf, MD, MPH, MBA, as Its First-Ever Chief Medical Officer
06/02/2018
CHICAGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018
06/02/2018
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018
06/02/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]
VALNEVA : Déclaration d'actions et de droits de vote - Janvier 2018
06/02/2018
VALNEVA Déclaration d'actions et de droits de vote - JANVIER 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Poster presentation at WORLDSymposium™ 2018 – arimoclomol as clinical candidate for treatment of Gaucher disease
06/02/2018
Investor news Orphazyme A/S No. 02/2018 Copenhagen, February 6, 2018 – Orphazyme A/S , a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, today announced [...]
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February
06/02/2018
LONDON and CARLSBAD, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
V ClinBio Acquires 49.98% Stake in Cellix to Advance Synergix, a Transformative Pro-drug Technology Platform
06/02/2018
- Lead compounds for the treatment of relapsing-remitting multiple sclerosis and ulcerative colitis on target to enter clinic in 2018 - PRINCETON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- V ClinBio Inc., an innovative [...]
Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018
06/02/2018
ATLANTA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) today announced that its Special Meeting of Stockholders, scheduled for and convened on February 6, 2018, has been adjourned to [...]
AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand
06/02/2018
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, announced today that it has entered into a binding distribution [...]
Xoc Pharmaceuticals Announces $30 Million Series A Financing Led by NEA
06/02/2018
LOS GATOS, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Xoc Pharmaceuticals, Inc., a privately-held, early-stage biopharmaceutical company focused on the development of innovative therapeutics for diseases of the central [...]
Sienna Announces Q4 2017 Results Release Date and Conference Call
06/02/2018
MARKHAM, Ontario, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA ) announced that it will report its 2017 fourth quarter results after market close on Thursday, [...]
Biothera Pharmaceuticals Commences Phase 2 Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)
06/02/2018
EAGAN, Minn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. announced today that patient treatment has commenced in its Phase 2 clinical study in squamous cell carcinoma of the head and neck (SCCHN). [...]
Galectin Therapeutics to Present at BIO CEO & Investor Conference
06/02/2018
NORCROSS, Ga., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber, M.D., the Company’s [...]
Medipure Pharmaceuticals Inc. Announces Appointment of Dr. Kaiji Hu as Research Scientist - Cell and Molecular Biology
06/02/2018
VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Medipure Pharmaceuticals Inc., a biopharmaceutical incubator committed to discovering and developing proprietary cannabinoid-derived prescription [...]
When It Comes to Artificial Intelligence in Healthcare, Patients Fear the Replacement of Doctors, Yet Are Open to AI Nurse Support
06/02/2018
RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health Communications today released a report that provides pioneering perspectives into patients’ thought processes as they confront a future with artificial [...]
NewLink Genetics to Participate in Upcoming Investor Conferences
06/02/2018
AMES, Iowa, Feb. 06, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will participate in the following investor conferences: BIO CEO & Investor Conference, [...]
Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance
06/02/2018
BOSTON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ) today responded to unfounded rumors regarding possible financing plans of the Company. Management states that it knows of no developments [...]
Aino Health AB (publ): signs contract with ArcelorMittal
06/02/2018
Aino Health Germany GmbH has signed a contract with the German steel and mining company ArcelorMittal regarding use of Aino's health management services at the factory in Neuwied. The deal is the first on the German [...]

Pages